Press release
Malaria Vaccines Market Complete Analysis by Competitive Landscape to 2026 - GlaxoSmithKline, GenVec, Inc., Nobelpharma, Sanaria, Cadila Healthcare Ltd., Genome ReS Ltd,
The malaria vaccines market is expected to reach USD 156.8 million by 2026 according to a new study published by Polaris Market Research.
Request Sample for more Professional and Technical insights @
https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market/request-for-free-sample
A few key strategies adopted by companies operating in the malaria vaccines market are new technology and product development, and geographical expansion among the developing regions to focus on proving vaccines to the areas highly affected by the disease at lower cost. World Health Organization (WHO), in 2015, around 292,000 children died of malaria, at the young age of 5 years in Africa. There were around 306,000 fatalities associated with malaria that was reported worldwide in 2015, out of which around 90% cases were found in Africa. This scenario shows the rising need for empathy towards the disease as well as higher demand for low cost vaccinations.
Geographically, the Asia Pacific region is expected to grow at the fastest rate among all the other regions with Middle-east & Africa and Latin America likely to be the other potential regions for market. North America and Europe have considerably lower cases of malaria related diseases with regions such as Latin America and MEA monitoring some of the highest deaths of children related to malaria globally.
The leading players operating in the Malaria Vaccines Market globally are: -
• GlaxoSmithKline
• GenVec Inc.
• Nobelpharma
• Sanaria
• Cadila Healthcare Ltd.
• CellFree Sciences Co. Ltd.
• VLP Therapeutics LLC
• Genome ReS Ltd.
For 'Queries' related to this research report, Make an Enquiry @
https://www.polarismarketresearch.com/industry-analysis/malaria-vaccines-market/inquire-before-buying
A few key factors boosting the malaria vaccines market are the growing incidences of malaria along with the presence of numerous companies that are introducing low profit margin vaccines across the world.
Moreover, rising awareness related to the aftermaths of the disease, together with growing diagnosis and higher treatment rate are a few other driving factors boosting the market globally. However, it is high price of vaccines, and weaker supply chain or distribution network in the developing countries among others that act as some of the major restraints for the market growth of malaria vaccines globally. It is expected that the ongoing research activities along with alarming death rates by malaria will further provide numerous opportunities for the growth of the Malaria Vaccines Market in the upcoming years.
The market for malaria vaccines globally has been divided based on vaccine type, agent, channel of distribution and region. Considering the vaccine type, the market is bifurcated into pre-erythrocytic vaccine, erythrocytic vaccine, and multi-antigen vaccine.
The channel of distribution used for malaria vaccines include the hospitals, clinics and community centers.
Considering the agent used in the malaria vaccines, the global market is divided into plasmodium falciparum, anopheles species, and plasmodium vivax.
Partial TOC of Malaria Vaccines Market: -
1. Industry snapshot
2. Ecosystem analysis
3. Market Dynamics
4. Industry analysis - Porter's five force
5. Degree of competition
6. Market PEST Analysis
7. Market Value Chain Analysis
8. Industry Trends
9. Competitive Ranking Analysis
About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Malaria Vaccines Market Complete Analysis by Competitive Landscape to 2026 - GlaxoSmithKline, GenVec, Inc., Nobelpharma, Sanaria, Cadila Healthcare Ltd., Genome ReS Ltd, here
News-ID: 1379056 • Views: …
More Releases from Polaris Market Research & Consulting
Data as a Service Market on Track to Hit USD 125.40 Billion By 2032, Propelled b …
According to a new market research report published by Polaris Market Research, the global Data as a Service Market is expected to grow at a CAGR of 30.00% from 2024 to 2032. The potential to offer firms worth of their data benefits and permit them to provide their substantial data to outermost parties effortlessly are anticipated to drive market expansion.
The global market was valued at USD 11.87 billion in…
Maritime Satellite Communication Market Trends Analysis & Growth Factor is Expec …
According to a new market research report published by Polaris Market Research, the global Maritime Satellite Communication Market was valued at USD 4.18 billion in 2023 to USD 8.35 billion by 2032, disclosing a CAGR of 8.20% during the forecast period of 2024-2032. Growing demand for voice communication solicitation in several sectors, including passenger ships, fishing, and marine shipping, is anticipated to drive market expansion.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:…
Form Fill and Sealing (FFS) Equipment Market With Exhibiting a CAGR of 7.20% to …
𝐓𝐡𝐞 𝐫𝐞𝐜𝐞𝐧𝐭𝐥𝐲 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐅𝐨𝐫𝐦 𝐅𝐢𝐥𝐥 𝐚𝐧𝐝 𝐒𝐞𝐚𝐥𝐢𝐧𝐠 (𝐅𝐅𝐒) 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐭𝐮𝐝𝐲 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐯𝐞𝐚𝐥𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐔𝐒𝐃 8361.79 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023, 𝐰𝐢𝐭𝐡 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 7.20% 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐟𝐫𝐨𝐦 2024 𝐭𝐨 2032. 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐨𝐟𝐟𝐞𝐫 𝐚𝐧 𝐚𝐛𝐬𝐨𝐥𝐮𝐭𝐞 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐨𝐟 𝐔𝐒𝐃 15,607.07 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2032.
The growing acquisition of many kinds of inventive technologies involving motion regulation or human-machine boundaries and the escalated…
Peppermint Oil Market Envisioned to Reach US$ 673.25 Million by 2032, Growing at …
The Global Peppermint Oil Market reached USD 377.48 million in 2023 and is expected to reach USD 673.25 million by 2032, growing at a CAGR of 6.70% from 2024 to 2032.
𝐆𝐚𝐢𝐧 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐎𝐮𝐫 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/peppermint-oil-market/request-for-sample
The peppermint plant, which grows well in North America and Europe, is the source of peppermint oil. Menthol is a chemical found in peppermint. Menthol is attributed to many of the…
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%.
An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the…
